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ABSTRACT
Fibropapillomatosis (FP) is a tumor-forming sea turtle disease that mainly affects
juvenile green turtles (Chelonia mydas) in coastal foraging sites. The cause of FP is unclear, but
likely involves the putative pathogen chelonid herpesvirus 5 (ChHV5). The overall dynamics of
this disease are poorly understood, in part due to the difficulty of inferring disease and infection
statuses of turtles without evidence of FP. In this study, I investigated the FP disease system in
juvenile green turtles of the Indian River Lagoon (IRL), Florida, USA, to better understand
disease and pathogen dynamics. First, I developed a hierarchical model for predicting FP
development and disease state progression. The results of the hierarchical model estimated >99%
of juvenile green turtles in the IRL developed FP, indicating that nearly every individual in the
IRL is affected by this disease. The model also suggested that turtles quickly developed FP upon
recruitment to the IRL and then recovered at different rates, with most completely recovering
before emigrating from the IRL as they mature. Second, I assessed the viability of using qPCR of
blood and skin samples to assess ChHV5 infection dynamics. I found very low prevalence of
ChHV5 infections in blood (1.4% positive) and skin (6.5% positive) samples, and high
prevalence in tumor samples (89.7% positive). Considering the high prevalence of FP in the IRL,
and the high detection prevalence of ChHV5 from tumor samples, qPCR testing of blood and
skin samples was ineffective for identifying ChHV5 infection status of individual turtles.
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CHAPTER ONE: INTRODUCTION
Infectious diseases are an ongoing topic of concern in conservation biology (Daszak et al.
2000, Tompkins et al. 2015). Well-known diseases such as chytridiomycosis in amphibians,
chronic wasting disease in cervids, and white-nose syndrome in bats have severely affected or
extirpated many wildlife populations in recent history (Skerratt et al. 2007, Edmunds et al. 2016,
Hoyt et al. 2021). But these highly virulent diseases represent a small proportion of those that
currently exist in wildlife populations. There are countless diseases that have persisted in natural
ecosystems with varying levels of detrimental effects on their hosts. However, it is still important
to understand and track less-virulent wildlife diseases for conservation purposes, particularly
with various anthropogenic changes likely to affect the dynamics of many diseases (Daszak et al.
2001, Tompkins et al. 2015). We need only look at the COVID-19 pandemic to see that diseases
can rapidly change in virulence and impact, and the same can happen with wildlife diseases.
Thus from a conservation biology standpoint, we should carefully monitor and attempt to fully
understand any wildlife disease that could potentially impact species of conservation concern.
One such disease is fibropapillomatosis (FP), a tumor-forming disease in sea turtles (Herbst
1994). While FP can be fatal, most turtles fully recover from FP and it is generally not
considered to have a major effect on sea turtle populations (Work et al. 2004, Chaloupka et al.
2008, Flint et al. 2010, Hargrove et al. 2016, Patrício et al. 2016). However, much of the
dynamics of FP are poorly understood, and further research is required to better understand many
aspects of this disease.
In this thesis, I investigated the dynamics of FP and its putative pathogen chelonid
herpesvirus 5 (ChHV5) in a foraging aggregation of juvenile green turtles (Chelonia mydas) in
1

the Indian River Lagoon, Florida, USA. I conducted two separate studies on this system. In the
first study, I developed and applied a hierarchical model to predict FP development and disease
state progression using capture-recapture data from a long-term monitoring dataset. In the second
study, I evaluated the viability of using quantitative polymerase chain reaction (qPCR) testing of
blood and skin samples to assess ChHV5 infection dynamics. Each of these studies are presented
here in successive chapters, and are intended to be submitted as stand-alone journal articles. As
such, each chapter has self-contained introductions and subject matter, and there may be some
overlap in presented material between the two chapters. Additionally, the use of the pronoun
‘we’ and its variations are used frequently in this thesis to reflect the collaborative nature of the
research conducted. All coauthors of the intended publications from the chapters of this thesis
are noted in the Acknowledgments section.
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CHAPTER TWO: NOVEL DISEASE STATE MODEL FINDS MOST
JUVENILE GREEN TURTLES DEVELOP AND RECOVER FROM
FIBROPAPILLOMATOSIS
Summary
Fibropapillomatosis (FP) is a sea turtle disease characterized by benign tumor development
on skin, eyes, and/or internal organs. It primarily affects juvenile green turtles (Chelonia mydas)
in coastal foraging sites. The Indian River Lagoon (IRL), Florida, USA, is a coastal green turtle
foraging site where the observed FP annual rate averaged 49% between 1983 and 2018. While FP
is no longer considered a major cause of sea turtle mortality and most individuals fully recover,
the overall dynamics of this disease are poorly understood because prior disease history is
unknown for individuals without FP at capture time, and future disease outcome is unknown for
individuals with FP at capture time. To better evaluate FP dynamics for green turtles in the IRL,
we developed a hierarchical model for predicting disease state change. We used data from 4,149
captures of 3,700 individual green turtles captured in the IRL. The hierarchical disease state model
contained two levels: level one modeled whether an individual would develop FP, and level two
modeled disease state progression, including states for pre-FP affliction, active FP affliction, and
full recovery from FP. From the hierarchical model, we estimated 99.8% (95% credibility intervals
99.1-100%) of juvenile green turtles in the IRL developed FP, indicating that nearly every
individual in the IRL is affected by this disease. The model also suggested that turtles quickly
developed FP upon recruitment to the IRL and then recovered at different rates, with most
completely recovering before emigrating from the IRL as they mature. This is the first analysis of
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long-term sea turtle data suggesting nearly every turtle in an aggregation both develops and
recovers from FP.

Introduction
Fibropapillomatosis (FP) is a sea turtle disease found in every ocean basin and documented
in all seven species in this group (Herbst 1994, reviewed in Jones et al. 2016). FP affects juvenile
green turtles (Chelonia mydas) in coastal habitats and is characterized by the proliferation of
benign tumors on the skin, eyes, and/or internal organs of afflicted individuals (see Figure 1)
(Lucké 1938, Smith and Coates 1938, Herbst 1994). Severe tumors may impair an individual by
hindering locomotion, obstructing vision, and disrupting organ functions (Brooks et al. 1994,
Herbst 1994, Foley et al. 2005; Chaloupka et al. 2008). These and other complications from FP
can be the cause of death for some turtles (Work et al. 2004, Chaloupka et al. 2008, Flint et al.
2010). However, FP does not appear to be a major cause of mortality in sea turtles overall
(Borrowman 2008, Patrício et al. 2011, Hargrove et al. 2016, reviewed in Jones et al. 2016). Full
regression of FP tumors occurs naturally (Ehrhart 1991, Hirama and Ehrhart 2007, Machado
Guimarães et al. 2013, Patrício et al. 2016), and most turtles afflicted with FP fully recover from
the disease (Hargrove et al. 2016, Patrício et al. 2016). The causes of FP are unclear, but are likely
a multifactorial etiology involving an infectious pathogen along with environmental and
immunological factors (Aguirre 1991, Herbst 1994). Chelonid herpesvirus 5 (ChHV5) is
significantly associated with FP tumors (Herbst et al. 1995, Quackenbush et al. 1998). Green
turtles typically become infected with ChHV5 and develop FP while still immature and occupying
coastal developmental foraging sites (Herbst 1994, Ene et al. 2005, Foley et al. 2005, Hirama and
4

Ehrhart 2007, Patrício et al. 2016). Green turtles have several distinct life-stages, spending the first
couple years of their lives in offshore habitats, then shifting to coastal habitats as larger juveniles
and eventually moving on to adult foraging sites near maturity (Lutz et al. 1997; Mansfield et al.
2021b). Fibropapillomatosis is common in the coastal juvenile life-stage of green turtles and is
absent or rare in other life-stages (reviewed in Jones et al. 2016).

Figure 1: Images of juvenile green turtles afflicted with fibropapillomatosis. Photo credit: Jake
Kelley; UCF MTRG (permits NMFS #19508 and Florida MTP-231).

The Indian River Lagoon (IRL) is a mixed-stock juvenile green turtle foraging site on the
east central coast of Florida, USA (Bagley 2003) in the western North Atlantic. It is also the
location of a long-term (1982-present) sea turtle mark-recapture program conducted by the
University of Central Florida Marine Turtle Research Group (UCFMTRG). Over the course of this
IRL study, over 3,000 green turtles were captured and prevalence of FP among these turtles
averaged 49% (Hirama and Ehrhart 2007). The duration of this study, number of captures, and
5

high FP prevalence makes this dataset one of the largest and most complete FP datasets for green
turtles at a single site. Despite these extensive data, assessing the dynamics of FP remains difficult
because of multiple unknowns related to sampling. Recapture rates in the IRL are just 10% for
green turtles, thus long-term FP histories across multiple captures are relatively limited. If a turtle
is captured without FP, no straightforward method exists to determine whether the turtle did or did
not previously have FP and subsequently recover. Testing for ChHV5, the putative pathogen of
FP, is not reliable for non-tumor tissues (Quackenbush et al. 2001, Page-Karjian et al. 2015,
Lawrance et al. 2018) further limiting insight for turtles without visible external FP tumors at the
time of sampling. More information on probable disease state for each turtle capture (healthy,
afflicted with FP, recovered from FP) would allow for advancements in our understanding of FP
dynamics including questions about why some turtles get FP but not others, timing of FP
progression, and what factors affect severity and length of time of individual FP affliction. Here,
we developed a hierarchical model for disease state that provides insights into FP dynamics in the
IRL. This model can be extended to further assessments of FP on a global scale.

Methods
Study site and long-term data collection
The UCFMTRG conducted netting sessions for sea turtle sampling in the IRL
(approximately 27.8312 N, -80.4395 W; Figure 2) starting in 1982 (Ehrhart et al. 2007). These
sampling sessions typically occurred twice a month; 961 sessions occurred from 1982 through
2018. During each sampling event, UCFMTRG captured turtles using a 455-meter-long large6

mesh entanglement net that had a soak time of up to three hours per session (Ehrhart et al. 2007).
All captured turtles were tagged (flipper tags and/or PIT tags) using standardized protocols (Balazs
1999) to keep track of individuals during any subsequent captures. Data we collected from each
turtle and each capture event included straight-carapace-length (SCL, a standard size measurement
for turtles; Bolten 1999), FP status (presence/absence of external FP tumors), and capture date. We
used data from 4,149 captures of 3,700 individuals from 1983 to 2018 in our analyses. We verified
there were no major and obvious errors (besides small measurement error) in recorded SCL values
and excluded any capture data with missing SCL values. Because transient adult green turtles were
occasionally captured, we also excluded turtles greater than 79.9 cm SCL from our dataset to
minimize mixing animals at contrasting developmental stages.

Figure 2: Map of Indian River Lagoon study location on the east, central coast of Florida, USA.
This is the site of a long-term juvenile sea turtle sampling program conducted by UCFMTRG.
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Data summarization and initial statistical analyses
We summarized the data and conducted all statistical analyses using the program R version
3.5.2 (R Core Development Team 2021). This included creating histograms and plots of FP status
variation by size (SCL), season, and year. We defined Northern Hemisphere seasons by monthly
groupings, where March-May were grouped as Spring, June-August were grouped as Summer,
September-November were grouped as Fall, and December-February were grouped as Winter.
We used logistic regression models to investigate the interactive effects of size (SCL) and
season on probability of FP occurrence. Because of the non-linear shape of their relationship, we
evaluated FP status as a quadratic polynomial function of logarithm-transformed SCL considering
variation among seasons. We compared four models: one with interactive effects of SCL and
season, one with additive effects of SCL and season, one with just SCL, and one with just season.
We ran the models in a Bayesian framework using the program OpenBUGS version 3.2.3
via the R package R2OpenBUGS (Lunn et al. 2000, Sturtz et al. 2005). We used uninformed priors
and set the MCMC settings to three chains of 3,000 iterations with a 1,000-iteration burn-in and
chains thinned by two. We verified convergence of the model by inspecting trace-plots and
verifying Rhat values were less than 1.1 for all parameters. We evaluated goodness of fit by
inspecting graphical plots of posterior predictive checks. We used deviance information criterion
(DIC) values to compare the models and evaluated the results for the model with the lowest DIC.
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Hierarchical modeling of FP state
Recapture rates in the IRL are relatively low, with most individuals only captured one or
two times. Low recapture rates limit direct insight on disease status and progression over time for
each turtle in the IRL because each capture represents a narrow snapshot of an individual’s time
in the IRL. Thus, to allow for inference on FP state with limited recapture data, we developed a
Bayesian hierarchical model to predict FP state of green turtle captures based on SCL. By using
SCL as an explanatory variable, we assumed that size-specific capture probabilities did not vary
between FP and non-FP turtles (see discussion for more detail on how this could affect results).
To establish our FP states of interest, we defined state 0 as having not yet developed FP, state 1 as
having FP, and state 2 as having fully cleared FP (see Figure 3). Because data were not available
for disease state at every capture, we developed a dataset for FP state based on available
information, where each turtle capture was assigned a binomial value for each FP state (0 for not
belonging to that state, 1 for belonging to that state, NA if not enough information to assign a value
for that state). Every turtle captured with FP was assigned to state 1, and those without FP were
assigned as not belonging to state 1. However, for turtles captured without FP, it is impossible to
tell if that capture is state 0 or state 2 without appropriate recapture data. If a turtle captured without
FP had a subsequent capture with FP, the capture was assigned to state 0. Likewise, if a turtle
captured without FP had a preceding capture with FP, that capture was assigned to state 2. Any
capture without enough information to determine state 0 or 2 was not assigned a value for those
states (left as NA). The resulting dataset included binomial information (0, 1, or NA) for belonging
to each disease state (state 0 – pre-FP, state 1 – FP, state 2 – post-FP) for each of the 4,149 green
turtle captures.
9

A diagram of the model system is in Figure 3 and the full model structure is shown in Table
1. The first level of the model is a logistic regression to predict whether an individual turtle will
develop FP or not (Figure 3 – Box A). This level of the model could also be used to assess factors
of interest that may impact whether or not a turtle develops FP, such as which nesting beach or
oceanic habitat the turtle came from, diet, genetic factors, toxicology factors, immune factors like
MHC genes (e.g., Martin et al. in review), and many others. However, in this study, we did not
evaluate factors affecting FP development and assumed random FP development. The second level
is a modified ordinal logistic regression to model the progression of FP through each disease state
based on SCL (Figure 3 – Box B). An ordinal logistic regression allows for ordered transition from
disease state 0 to state 1, and then state 1 to state 2, with no backward movement. We used an
ordinal logistic regression because there were no cases of an individual developing tumors again.
If intermittent FP occurs it likely only occurs during a brief period rather than many years later,
and would not impact the general structure of the model. We made modifications to the standard
ordinal logistic regression to allow for different slopes, which was necessary since transitions from
state 0 to 1 and state 1 to 2 likely occurred at different rates.

10

Figure 3: Diagram of the FP system for green turtles in the Indian River Lagoon, FL as it relates
to the hierarchical model of FP state. The first level of the model is a logistic regression that
determines what happens in Box A. The second level of the model is a modified ordinal logistic
regression that determines what happens in Box B.
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Table 1: Specification and structure of the Bayesian hierarchical model of fibropapillomatosis
(FP) state for green turtles in the Indian River Lagoon (IRL). Fibropapillomatosis state 0 is
defined as never having had FP, state 1 is currently having FP, and state 2 is having recovered
from FP.
Hierarchical levels
Level 1 –
Logistic regression
for probability a
turtle develops FP
while in the IRL

Model structure

Definition of terms
i = each turtle capture
ZFP = whether or not a capture develops FP
while in the IRL
ψFP = probability of a turtle developing FP
while in the IRL

ZFP[i] ~ Bernoulli(ψFP[i])
logit(ψFP[i]) <- logit(int.FP)

Z2[i] ~ Bernoulli(ZFP[i] * ψ2[i])
logit(ψ2[i]) <- logit(1 - ψ1cum[i])
Level 2 –
Modified ordinal
logistic regression
for progression
through FP states
based on SCL

Z1[i] ~ Bernoulli(ZFP[i] * ψ1[i])
logit(ψ1[i]) <- logit(ψ1cum[i] – ψ0[i])
logit(ψ1cum[i]) <- logit(S1 * (1 – int.psi0)
+ int.psi0) – S2 * βSCL * SCL[i]
Z0[i] ~ Bernoulli(ZFP[i] * ψ0[i])
logit(ψ0[i]) <- logit(int.psi0) – βSCL *
SCL[i]
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Z2 = whether or not a capture is FP state 2
ψ2 = probability a capture is FP state 2,
provided the turtle will develop FP in the IRL
Z1 = whether or not a capture is FP state 1
ψ1 = probability a capture is FP state 1,
provided the turtle will develop FP in the IRL
ψ1cum = cumulative probability a capture is FP
state 0 or 1, provided the turtle will develop FP
in the IRL
Z2 = whether or not a capture is FP state 0
ψ0 = probability a capture is FP state 0,
provided the turtle will develop FP in the IRL
Other terms:
int.FP and int.psi0 are intercept parameters
between zero and one
S1 and S2 are scalars between zero and one
βSCL is a positive coefficient
SCL[i] is the straight-carapace-length of each
capture

We ran the model with OpenBUGS and R via the R package R2OpenBUGS. We used
uninformed priors and set the MCMC settings to three chains of 80,000 iterations with a 20,000iteration burn-in and chains thinned by two. We verified convergence of the model by inspecting
trace-plots and verifying Rhat values were less than 1.1 for all parameters. We evaluated goodness
of fit by inspecting graphical plots of posterior predictive checks.

Data and code access
All data and code used in this study are publicly available on Dryad (Mansfield et al. 2021a;
doi:10.5061/dryad.ttdz08kzn).

Results
Data summarization and initial statistical analyses
The green turtle capture dataset from the IRL included 4,149 captures of 3,700 individuals,
388 of which were captured at least twice and 53 of which were captured at least three times. Of
the 388 turtles captured at least twice, 53 were captured without FP and subsequently captured
with FP, and 72 were captured with FP and subsequently captured without FP. Of the 53 turtles
captured at least three times, there were no cases of recurring FP, where an individual had FP,
recovered, and then was captured again with FP. For those turtles with three or more captures, four
individuals were first captured without FP, then with FP, and then again recovered from FP; 12
individuals did not have FP at any capture; 15 individuals had FP at every capture; nine went from
not having FP to having FP; and 13 went from having FP to not having FP. The long-term annual
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average FP rate (proportion of green turtle captures with FP) was 0.49 (0.10 standard deviation),
and the overall FP rate of the entire dataset was 0.51. Green turtles captured in the IRL and included
in this study ranged from 22.0 to 78.6 cm SCL, with most captures between 30 and 60 cm SCL
(Figure 4). There was a positive skew in SCL of green turtle captures, which could represent
variation in size at permanent emigration from the IRL and/or differences in size-specific capture
rates. Fibropapillomatosis rates were highest for turtles between 30 and 50 cm SCL (Figure 5A).
There were small fluctuations in FP rates over time, typically ranging between 0.4 and 0.6, with a
small spike in FP rates during the late 1990s (Figure 5B). FP rates were highest in Fall and Winter
(Figure 5C).

Figure 4: Histogram of straight-carapace-lengths (SCL) and FP status for juvenile green turtles
captured in the Indian River Lagoon, FL from 1983 to 2018.
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Figure 5: Proportions of juvenile green turtles with FP captured in the Indian River Lagoon, FL
from 1983 to 2018 based on (a) SCL, (b) Year, and (c) Season.

The most informative logistic regression model for FP occurrence based on DIC included
interactive effects of SCL and season (Table 2). Fibropapillomatosis probability was higher during
the Fall season for turtles less than approximately 45 cm SCL, but there were no differences
between seasons for larger turtles (Figure 6). For all seasons, FP probability increased with SCL
until about 35-40 cm SCL and decreased thereafter (Figure 6).

Table 2: Comparison of deviance information criterion (DIC) values of logistic regression
models for FP status with covariates SCL and season. For these models, the covariate SCL was
considered as the quadratic of the logarithm transform of SCL. The top model included the
interactive effects of SCL and season.
Model
FP ~ (logSCL)^2 + logSCL +
(logSCL)^2:Season + logSCL:Season + Season
FP ~ (logSCL)^2 + logSCL + Season
FP ~ (logSCL)^2 + logSCL
FP ~ Season

DIC
5141
5148
5184
5715
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Figure 6: Results of a logistic regression model of FP probability based on interactive effects of
season and the quadratic of logarithm transformed SCL. Dotted lines represent 95% credibility
intervals. Fall was the only season that significantly affected FP probability, so this model
grouped all other seasons besides Fall for better visual representation of the results.
Fibropapillomatosis probability was higher in Fall for smaller turtles (< 45 cm SCL).
Hierarchical modeling of FP state
The Bayesian hierarchical model of FP state reached convergence, and graphical plots of
posterior predictive checks indicated good fit of the model and data. From level one of the model,
an estimated 99.8% (95% credibility intervals 99.1-100%) of juvenile green turtles in the IRL
developed FP, indicating that nearly every individual in the IRL is affected by FP. Level two of
the model indicated that turtles quickly develop FP upon recruitment to the IRL and then recover
at different rates, with most completely recovering before permanently emigrating from the IRL.
The smallest turtles (<30 cm SCL) had a relatively high probability of being FP state 0, but by
approximately 35 cm SCL there was a very low probability of a turtle being FP state 0 (Figure 7a).
Small to intermediate sized turtles (approximately 35 to 45 cm SCL) were most likely to be FP
state 1, and this tracked very closely to the results of logistic regression analysis (Figure 7b).
16

Fibropapillomatosis state 2 probability steadily increased with SCL (Figure 7c). The model
predicts that almost every turtle (approximately 93%) will develop FP by 40 cm SCL, and over
90% fully recover by 65 cm SCL (Figure 7d).

Figure 7: Results of the Bayesian hierarchical model of FP state for green turtles in the Indian
River Lagoon, FL. Dotted lines represent 95% credibility intervals. Each panel represents the
probability of a turtle being in a particular FP state based on SCL, including (a) FP state 0 [never
had FP], (b) FP state 1 [FP present], (c) FP state 2 [recovered from FP] and (d) the cumulative
probabilities of FP states 1 and 2 [has FP or has had FP]. Turtles quickly transition from state 0
to state 1, with about 80% of turtles developing FP by 35 cm SCL. Then turtles recover from FP
at different rates, resulting in gradual transition from state 1 to state 2 (recovered). Over 90% of
turtles fully recover from FP by 65 cm SCL.
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Discussion
This study presents a modeling approach to assess the fibropapillomatosis disease system
in juvenile green turtles, revealing insights into FP dynamics. We found that almost every resident
juvenile green turtle in the IRL study site likely develops FP and subsequently recovers, at least
from visible FP (we did not evaluate turtles for the presence of internal, non-visible tumors). This
is the first analysis of long-term sea turtle data that suggests nearly every turtle in an aggregation
develops and recovers from FP.

Potential for differential capture probability to affect hierarchical model
One major assumption of our hierarchical modeling approach was that there must be no
differences in capture probabilities between FP and non-FP turtles of the same size. If presence of
FP tumors affects capture probability, it could bias model results if not accounted for because
capture data would be skewed towards whichever group has higher capture probabilities.
Therefore, it is important to consider potential differences in capture probabilities among FP and
non-FP turtles. Due to the nature of our dataset, we were unable to statistically assess capture
probabilities. Instead, we conceptually reviewed the capture process for our study and carefully
considered where differences could occur before proceeding with our hierarchical modeling
approach.
Capture probability in this system could be described by two processes: the probability of
being available for capture (in the IRL and near the net), and the probability of getting tangled in
the net. The process of getting tangled in the net could be biased if FP turtles are more likely to be
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captured due to the tendency for FP tumors to get tangled in or snagged by the net. Other factors
may also contribute to differences in getting tangled between FP and non-FP turtles, including
potential differences in turtle activity, vision, and swimming ability. However, tangling probability
is a relatively insignificant process compared to availability probability. Recapture rates were very
low (<10% overall, estimated 4% annual recapture probability; Borrowman 2008) for green turtles
in the IRL, likely because the IRL is large and the probability of an individual turtle being available
for capture at the discrete netting site is very low. Therefore, availability is the driving factor in
capture probability, so much so that differences in getting tangled are likely negligible in overall
capture probability within our study.
Another question is whether FP status causes differences in availability at the sampling
site. Differences in behavior, survival, and size at permanent emigration among FP and non-FP
turtles could lead to differences in availability. However, previous research suggests FP does not
have a major effect on growth rates or survival, including in the IRL (Borrowman 2008). There is
currently no evidence to suggest there are differences in size at emigration for FP and non-FP
turtles, and FP is rare to nonexistent in subadult/adult foraging sites, suggesting turtles generally
do not have FP at the time of emigration. Distinct behavioral differences between FP turtles and
non-FP turtles have never been documented, except for severe cases of FP which are relatively
uncommon in IRL captures (Hirama and Ehrhart 2007). However, there may still be a subset of
turtles that are severely affected by FP in the IRL and are rarely captured due to behavioral
differences, and therefore not included in this analysis.
The fact that the IRL is an open system where turtles are free to come and go could affect
availability at the study site based on FP status, particularly if there are transient turtles from other
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sites with differing FP dynamics. The effects of non-resident transient turtles on our model results
would depend on the source and number of such animals. For example, if large numbers of turtles
with FP briefly enter the IRL from other sites, that would likely result in an overestimation of the
proportion of turtles that get FP in the IRL. However, if large numbers of turtles without FP are
transient in the IRL, it would have minimal effect on our results because the bias would
underestimate FP rates of resident IRL turtles and our results already suggest high FP incidence.
There are also reasons to assume the IRL is a relatively closed system for juvenile turtles with
minimal effects of non-resident turtles. The IRL is connected to the Atlantic Ocean by very few,
relatively narrow inlets, which likely restricts free movement in and out of the lagoon system.
Another site on the ocean side of the IRL site (~ 2 km straight line distance, separated by a narrow
barrier island) was also monitored by UCFMTRG from 1989 to 2010 and was comprised of almost
entirely different turtles (<1% of individuals captured at both locations) of overlapping size-ranges
with completely different FP rates (Hirama and Ehrhart 2007). Juvenile green turtles often display
foraging site fidelity within coastal habitats (Mendonça 1983, Pilcher 2010, Shimada et al. 2014,
Colman et al. 2015, Hancock et al. 2018, Siegwalt et al. 2020). A short-term tracking study in the
IRL showed most turtles had small home-ranges at the IRL site (Redfoot and Ehrhart 2008), but
there are no long-term studies on site fidelity in the IRL. Relatively low recapture rates in the IRL
(~8%; Long et al. 2021) bring site fidelity into question, but the study site is very small (~1 square
km) relative to the useable area of the IRL, which may lead to low recapture rates when considering
the broader IRL system as a single foraging aggregation. Additionally, many turtles in this study
were recaptured across long periods of time (average time between recaptures was about 1.9 years,
with 25 turtles recaptured at least five years apart, UCF MTRG unpubl. data), implying some level
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of long-term site fidelity may exist. Thus, while it is possible that differences in FP capture
probability could bias our model results, there is no evidence to suggest substantial differences
exist. Future research could focus on evaluating long-term site fidelity and habitat use in the IRL,
which would also help clarify the validity of our model of FP state.

Fibropapillomatosis disease dynamics
This study showed that nearly every resident juvenile green turtle in the IRL develops and
recovers from FP. While this is the first report of near ubiquity of FP in a group of sea turtles, other
pathogens and diseases in wild, captive, and human populations have similarly high incidences
with minimal effects on populations, with examples including Mycoplasma in tortoises and birds
(Jacobson et al. 2014, Sawicka-Durkalec et al. 2021), Batrachochytrium dendrobatidis in bullfrogs
(Garner et al. 2005, Peterson et al. 2007, Schloegel et al. 2009), and herpesviruses in turtles,
elephants, and humans (Prober 2005, Hardman et al. 2011, Hidalgo-Vila et al. 2020). There are
likely many other green turtle aggregation sites that are also heavily affected by FP, but do not
have available data or data have not yet been analyzed. The IRL has a 49% FP rate, and other sites
have had similar or higher apparent FP rates, with examples including Hawaii (42-65%; Aguirre
and Lutz 2004), Espírito Santo Bay, Brazil (58%; dos Santos et al. 2010), Lake Worth Lagoon,
Florida (49%; Gorham et al. 2016), and Crystal River, Florida (68%; Chabot et al. 2021). Those
sites may also have every resident green turtle affected by FP, for at least a period of time, with
older residents having already recovered. But other sites still maintain no FP, low FP, or extremely
variable FP rates compared to the IRL, with some examples including Trident Submarine Basin,
Florida (~0-23%; Hirama and Ehrhart 2007, UCFMTRG unpubl. data), the worm-rock reef near
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the IRL site (~0-33%; Hirama and Ehrhart 2007, UCFMTRG unpubl. data), Corisco Bay, Gulf
Guinea (~10-27%; Formia et al. 2007), Hawaii (~0-60%; Chaloupka et al. 2009), and sites in
Puerto Rico (~0-80%; Patrício et al. 2016). Future comparisons of factors affecting FP dynamics
within and among these different sites could help clarify the epidemiology of FP.
What makes the IRL a hotspot for FP in green turtles? We developed several hypotheses
for this question based on previous research and results from this study: 1) High levels of ChHV5
are maintained in the IRL, leading to quick infections and FP development for green turtles in the
IRL. High environmental ChHV5 loads may be maintained by a consistent source of FP turtles or
super-spreader turtles described in Work et al. (2014), and may also be facilitated by leeches which
commonly parasitize IRL turtles and can harbor ChHV5 at high viral loads (Rittenburg et al. 2021).
In addition, relatively low water turnover rates in inshore habitats (like the IRL) compared to
coastal habitats could allow for accumulation of ChHV5 particles. 2) Poor water and habitat quality
due to runoff from nearby developed areas and attenuation of pollutants leads to green turtles
consistently developing FP in the IRL. Environmental pollutants have been suggested as potential
contributing factors for FP development, and FP rates are associated with inshore habitats with
lower water quality (Herbst 1994, Foley et al. 2005, dos Santos et al. 2010, Van Houtan et al.
2010). Additionally, stress from ontogenetic habitat and diet shifts that occur when juvenile green
turtles recruit from offshore to nearshore habitats (Bolten 2003, Jones and Seminoff 2013) may be
more severe in the IRL due to poor habitat quality, thereby promoting FP development. 3) Turtles
that use the IRL are genetically more susceptible to developing FP than those from other sites.
Though this hypothesis is unlikely since most juvenile green turtle foraging aggregations are
mixed-stock populations, it could contribute to some extent given individual-level variation in
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immune system genotypes (Martin et al. in review). And finally, 4) viral variants of ChHV5 in the
IRL are more virulent or more transmissible than those from other sites, leading to more infections
and higher FP incidence in the IRL. There are viral variants that are more common in the IRL than
other sites (Ene et al. 2005), but the complete extent of ChHV5 variation is not well-understood.
All of our proposed hypotheses are not mutually exclusive and could be valid in conjunction with
one another. The IRL system is ideal for future research to test these hypotheses on the etiology
of FP, particularly with comparisons of other juvenile green turtle foraging sites.
Aside from the high prevalence of FP in the IRL, this study also revealed other aspects of
FP dynamics in the IRL, including the progression of FP as a disease. Based on level two of the
hierarchical model, turtles appeared to quickly develop FP upon recruitment to the IRL. For
smaller turtles, FP probability was highest in Fall. Turtles may develop FP over the Summer and
into the Fall while temperatures are high (Herbst 1994), and by Fall the tumors have developed
enough to be seen. Then turtles could recover at different rates, which would explain the positive
skew in FP rates with SCL. Future work should investigate whether turtles recover at different
rates and assess what factors affect differential recovery rates, such as resource availability,
environmental factors, immune genes, or other genetic factors. Our model also suggests that nearly
every turtle completely recovers from FP in the IRL before typical permanent emigration size
(90% at 65 cm SCL); this makes sense given that FP is rare in adults (Work et al. 2004, reviewed
in Jones et al. 2016). Also of note were the relatively stable observed FP rates over time, with
annual FP rates typically ranging between 0.4 and 0.6. With green turtle populations growing and
a key finding of this study being that smaller green turtles in the IRL were more likely to have FP,
it might be expected that FP rates would increase over time as the size-structure of the IRL shifts
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towards a higher proportion of small turtles. However, our data did not show an increase in FP
rates over time, and notably there was no trend in size-structure over time in the IRL during this
study (Long et al. 2021).
The results of this study have potential positive and negative implications for sea turtle
conservation. Our model suggests that a prominent juvenile foraging site has almost all resident
green turtles affected by FP. The long-term effects of this are unclear because most work in the
IRL has been conducted after the emergence of FP in the region. For other sites with low or no FP,
introduction of ChHV5 and/or changes in environmental conditions could lead to similarly high
FP incidence. However, despite the prominence of FP in the IRL, green turtle populations are
showing exponential growth within regional rookeries, including those (e.g., Florida) rookeries
with stocks represented in the IRL (Seminoff et al. 2015). This could suggest that widespread mildto-moderate FP rates like we see in the IRL may have little impact on current population
trajectories, though further work is certainly required to fully characterize the conservation impacts
of FP on sea turtle populations.
Overall, there are still many unknowns in the FP disease system. The hierarchical model
structure presented here can be adapted and extended to other sites. For the purposes of this study,
we assumed FP randomly develops within the IRL juvenile aggregation; however, covariates can
(and likely should) be added to level one to assess factors affecting whether or not turtles get FP.
More generally, the practice of modeling a system piecewise in a hierarchical modeling framework
can be applied to many biological systems to provide more insightful results (Maunder and Punt
2013, Zipkin and Saunders 2018, Direnzo and Campbell Grant 2019).
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CHAPTER 3: VIABILITY OF QUANTITATIVE POLYMERASE CHAIN
REACTION TESTING OF BLOOD AND SKIN SAMPLES FOR
ASSESSING CHELONID HERPESVIRUS 5 INFECTION STATUS
Summary
Fibropapillomatosis (FP) is a tumor-forming sea turtle disease that mainly affects juvenile
green turtles. The cause of FP is unclear, but likely involves the putative pathogen chelonid
herpesvirus 5 (ChHV5). Presence and quantity of ChHV5 in blood and tissue can be evaluated via
quantitative polymerase chain reaction (qPCR) techniques. However, virus latency and
localization create uncertainty in ChHV5 qPCR testing of non-tumor tissues. In this study, we
assessed the viability of using qPCR of blood and skin samples to assess ChHV5 infection
dynamics. We tested a total of 675 blood, skin, and tumor samples collected from juvenile green
turtles in the Indian River Lagoon (IRL), Florida, USA, between 1995 and 2018. We found very
low prevalence of ChHV5 infections in blood (1.4% positive) and skin (6.5% positive) samples,
and high prevalence in tumor samples (89.7% positive). There were no clear statistical differences
in ChHV5 infection prevalence among non-tumor sample types, ages, or storage methods, likely
due to the low number of positive samples in all groups. Considering the high prevalence of FP in
the IRL, and the high detection prevalence of ChHV5 from tumor samples, qPCR testing of blood
and skin samples was ineffective for identifying ChHV5 infection if the infection status of the
animal itself (not just the sample) is the desired result. Therefore, qPCR of blood and skin samples
does not appear to be a viable option for characterizing ChHV5 infection dynamics, likely due to
the low probability of ChHV5 being present in a blood or skin sample.
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Introduction
Fibropapillomatosis (FP) is a sea turtle disease that commonly affects juvenile green turtles
in coastal habitats (reviewed by Jones et al. 2016). The cause of FP is not fully understood, but is
suggested to include infectious pathogens in conjunction with environmental and/or
immunological factors (Aguirre 1991, Herbst 1994). Chelonid herpesvirus 5 (ChHV5) is
associated with FP tumors and is the putative pathogen of FP (Herbst et al. 1995, Quackenbush et
al. 1998). While there is strong evidence that ChHV5 infection is necessary for FP to occur,
individuals can be infected with ChHV5 and present no signs of disease (Page-Karjian et al. 2015,
Lawrance et al. 2018). Therefore, the relative role of ChHV5 in the development of FP is unclear.
Investigations of the infection dynamics of ChHV5 are necessary to better understand the cause of
FP.
Chelonid herpesvirus 5 presence can be detected in blood and skin samples via quantitative
polymerase chain reaction (qPCR) techniques (Quackenbush et al. 2001, Page-Karjian et al. 2015).
While qPCR is highly sensitive (Page-Karjian et al. 2015), detection is imperfect because ChHV5
exhibits latency and localization, two traits that are common in herpesviruses (Roizman 1982).
Latency is when the virus exists in low quantities without causing ill-effects to the host. ChHV5
can be present in individuals without FP tumors, but latent ChHV5 infections can be difficult to
detect due to the low quantities of the virus (Roizman 1982). Localization is where the virus is
concentrated in particular areas or tissue types in the body, and absent or in low quantity in other
areas. ChHV5 shows strong localization in FP tumors, but can also be found in other locations
(Page-Karjian et al. 2015). The combination of localization and latency makes it difficult to
accurately test whether or not an individual turtle is infected with ChHV5 when it is not afflicted
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by FP tumors. This makes it difficult to assess ChHV5 dynamics in groups of turtles, complicating
research into the role of ChHV5 in FP development.
In addition to localization and latency issues affecting investigations of ChHV5, sample
age and storage techniques can impact the results of ChHV5 molecular analyses. Older archived
samples may have some DNA degradation that can limit qPCR efficiency, especially when target
DNA exists in low quantities as would be expected for a pathogen like ChHV5 (King et al. 2009,
Harkins et al. 2014, Muletz et al. 2014). Different sample storage techniques can also lead to
varying levels of DNA degradation (Kilpatrick 2001, Permenter et al. 2015). Older samples can
also be impacted by PCR inhibitors that limit the effectiveness of qPCR (King et al. 2009, Harkins
et al. 2014). Sea turtle blood and skin sample archives are often available from previous turtle
genetic studies and/or general sampling from long-term monitoring programs, and could be used
to assess ChHV5 infection dynamics. However, these sample archives are typically composed of
older samples with inconsistent sample collection and storage conditions over time. Therefore, it
is important to consider whether sample age and storage methods affect ChHV5 qPCR for
commonly collected blood and skin samples.
In this study, we assessed the viability of using qPCR of blood and skin samples to assess
ChHV5 infection dynamics in an aggregation of juvenile green turtles. We leveraged a large
temporal sample archive (1995-2018) of blood and skin tissues from juvenile green turtles with
and without FP collected by the University of Central Florida Marine Turtle Research Group
(UCFMTRG) in the Indian River Lagoon (IRL), Florida, USA. A recent study by Kelley et al. (in
press) suggests more than 99% of resident green turtles in the IRL become afflicted by and recover
from FP. If ChHV5 is indeed the pathogen associated with FP, then a large proportion of green
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turtles in the IRL should be infected with ChHV5, including those that have recovered from FP as
herpesviruses are known to cause lifelong infections (Roizman 1982). Here, we use a large sample
set that likely has high rates of ChHV5 infections to assess the viability of testing blood and skin
samples for individual and aggregation level infection dynamics. We assess ChHV5 qPCR results
based on FP status, sample type, sample age, and various storage methods to evaluate viability of
skin and blood qPCR for each of these factors.

Methods
Sample collection
The UCFMTRG conducted periodic sea turtle sampling sessions (typically twice each
month) in the IRL (approximately 27.8312 N, -80.4395 W) starting in 1982 (Ehrhart et al. 2007).
Turtles were captured using large-mesh entanglement nets and the presence/absence of external
FP tumors was recorded for each capture (Ehrhart et al. 2007, Kelley et al. in press). For turtles
captured with FP, evidence of tumor regression was noted based on the presence of smoothing,
rounded tumors (Hirama & Ehrhart 2007). Blood and tissue sample collection effort varied over
the course of the IRL study. From about 1995 to 2006, blood samples were collected primarily for
genetic studies, and skin was typically only collected if a blood sample could not be obtained.
Therefore, each individual would only have one sample type collected: blood or skin. Starting in
2014, both blood and skin sample collection were attempted for every individual. All blood
samples were collected from the dorsal cervical sinus, and typically stored in two ways: 1) a few
drops of blood were stored at room temperature in a lysis buffer solution (lysis buffer storage) and
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2) the remaining blood was spun to separate the plasma layer, with both the plasma and remaining
whole blood stored in a freezer in separate vials (frozen storage). Blood samples prior to 2006
were typically stored both ways, while samples after 2006 were typically only frozen storage, with
few also stored in lysis buffer. Skin samples prior to 2006 were collected from the fleshy portion
of either shoulder, and thereafter were collected from the fleshy portion of the trailing edge of
either rear flipper. All skin samples were stored in vials with 95% ethanol. Tumor tissue samples
were collected from turtles with external FP tumors starting in 2015. Tumor samples were stored
the same way as skin samples, in vials with 95% ethanol.
The availability of different sample types and storage methods in this archive varied
because sample collection varied over time and some samples may have been lost or compromised
over time, particularly older samples. As such, samples were analyzed opportunistically based on
what was collected and available for use. The resulting sample-set had an uneven distribution of
storage and sample types over time. Thus, we established the following groups for comparison:
blood – older lysis buffer (blood in lysis buffer collected from 1995-1999), blood – older frozen
(frozen blood collected from 2000-2006), blood – recent lysis buffer (blood in lysis buffer
collected from 2010-2013), blood – recent frozen (frozen blood collected from 2016-2018), skin
– older shoulder (shoulder skin samples collected in 1999), and skin – recent rear flipper (rear
flipper skin samples collected from 2016-2018). We also evaluated a subset of 39 turtles with FP
captured between 2016 and 2018 that had samples of blood, skin, and tumor tissues. This 20162018 sample group had consistent storage to allow for robust comparisons across sample types.
Overall, we assessed 513 blood samples, 123 skin samples, and 39 tumor samples from 573 green
turtles captured between 1995 and 2018 via molecular analyses.
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Molecular analyses
We used Qiagen DNeasy Blood and Tissue Kits to extract genomic g(DNA) from each
sample. For frozen blood samples, we followed the standard protocol for nucleated blood DNA
extraction with DNeasy Blood and Tissue Kit. For lysis buffer stored blood samples, we modified
the first step of the nucleated blood extraction protocol by using 200 μL of the lysis buffer sample
instead of 10 μL of blood with 190 μL of lead (II) sulfide (PbS). For skin and tumor samples, we
followed the standard DNA extraction protocol for tissue. We obtained two eluates for each DNA
extraction: a first eluate using just 50 μL of Buffer AE instead of the standard 200 μL to increase
DNA concentration, and a second eluate with 200 μL of Buffer AE to create a less concentrated
extraction. All DNA extractions were stored frozen until later analyses.
DNA concentrations of extractions were determined via a Nanodrop spectrophotometer.
Not all samples were assessed for DNA concentration because of limited volume yield for some
extractions and because some samples were used for other analyses, but we obtained DNA
concentrations for at least two thirds of each sample group (except tumors).
We tested DNA extractions for the presence and quantity (number of gene copies; viral
load) of ChHV5 using the qPCR protocol developed in Page-Karjian et al. (2015). Primers, probe,
and gene target for the qPCR protocol are shown in Table 3. We modified the qPCR protocol to
have 21.80 μL reactions containing 10 μL of SsoAdvanced Universal Probes Supermix (Bio-Rad),
0.80 μL of 10 μM forward primer, 0.80 μL of 10 μM reverse primer, 2.00 μL of 1 μM ChHV5 pol
probe, and 8.20 μL of DNA extraction template. For blood and skin samples, which are likely to
have low levels of ChHV5 if present, we used the first, more concentrated elution. For tumor
samples, which likely have high ChHV5 concentrations, we used the second, more dilute elution.
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Each qPCR plate included serial dilutions of a gBlock standard solution of the target sequence, a
positive control (known positive FP tumor DNA extraction), and a negative control (water).
Reactions followed the conditions in Page-Karjian et al. (2015): 10 min at 95°C, then 40 cycles of
30 s at 95°C and 1 min at 55°C. Reactions were run on a Bio-Rad CFX96 Real-Time System and
results were analyzed using Bio-Rad CFX Manager software v.3.1. Each sample was initially
tested once via qPCR. Samples that amplified before cycle 40 were considered potentially positive,
and all others were considered negative. Potentially positive samples were tested a second time via
qPCR and were only considered positive if the sample again amplified before cycle 40, and at least
one of the two runs amplified before cycle 38, with the rest of the samples being considered
negative. For positive samples, ChHV5 viral loads were determined by averaging the results of
both qPCR runs.

Table 3: Summary of chelonid herpesvirus 5 (ChHV5) qPCR primers, probe, and gene target.
Targeted gene

Primer sequence (5’ to 3’)

Probe

Length (bases)

DNA polymerase

F: AAC GCT TGC TTT TGG ACA AG

5’-6-FAM-TGG CCA TCA-

173

gene UL30

R: CCA GCG GGT GTG AAT AAA AT

ZEN-AGC TGA CGT GCA-3’

These are relatively relaxed standards for considering a sample as positive. We used these
criteria because blood and skin samples were likely to have low viral loads possibly near the limit
of detection for this qPCR assay, and we expected many samples to be considered negative by
stricter standards due to these low viral loads. We preferred to classify samples with good but
incomplete evidence of being positive as positive to give an upper limit to the extent which blood
and skin samples are viable at detecting a ChHV5 infection.
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Statistical analyses
We used a logistic regression analysis to evaluate differences in the probability of a sample
testing positive for ChHV5 via qPCR among sample groups (groupings based on sample type,
storage method, and collection timeframes summarized above, along with FP status). We intended
to include DNA concentrations of extractions as a covariate in the logistic regression analysis, but
there were insufficient data to do so. We summarized DNA concentrations among sample groups
using a boxplot. We also summarized viral loads for all positive samples by sample type using a
boxplot.
For the subset of 39 individuals with each of blood, skin, and tumor samples analyzed, we
conducted a separate set of analyses for a more robust comparison of ChHV5 infections and viral
loads across sample types. We used a logistic regression to evaluate differences in the probability
of a sample testing positive for ChHV5 via qPCR among sample types (blood, skin, and tumor).
We used bootstrapping with 1000 replications to estimate the mean viral loads with 95%
confidence intervals for positive samples for each sample type.
All statistical analyses were conducted in R version 4.1.0 (R Core Development Team
2021).

Results
We tested for ChHV5 via qPCR in 675 samples (513 blood, 123 skin, 39 tumor) from 573
juvenile green turtles captured between 1995 and 2018, including 292 without and 281 with
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external FP tumors at the time of sampling. Overall, just 1.4% and 6.5% of blood and skin samples
tested positive for ChHV5, respectively, while 89.7% of tumor samples tested positive (Table 4).
Only one of the 292 blood and skin samples from turtles without FP tested positive for ChHV5 –
a skin sample from a 44.8 cm SCL turtle captured in September 2018.

Table 4: Summary of chelonid herpesvirus 5 (ChHV5) qPCR test results for blood, skin, and
tumor samples of juvenile green turtles with and without fibropapillomatosis (FP) captured from
1995 to 2018 in the Indian River Lagoon, FL, USA. Viral load is shown in log genome
equivalents.
Sample
type

Blood

Skin

Tumor

Sample group description

ChHV5
prevalence FP turtles

ChHV5
prevalence No FP turtles

ChHV5
prevalence All turtles

Older blood in lysis buffer (1995-1999)
Older frozen blood (2000-2006)

4/74 (5.4%)

0/47 (0%)

4/121 (3.3%)

0/122 (0%)

0/121 (0%)

0/243 (0%)

Recent blood in lysis buffer (2010-2013)

1/28 (3.6%)

0/23 (0%)

1/51 (2.0%)

Recent frozen blood (2016-2018)

2/54 (3.7%)

0/44 (0%)

2/98 (2.0%)

All blood samples

7/278 (2.5%)

0/235 (0%)

7/513 (1.4%)

Shoulder skin (1999)

0/21 (0%)

0/12 (0%)

0/33 (0%)

Rear flipper skin (2016-2018)

7/45 (15.6%)

1/45 (2.2%)

8/90 (8.9%)

All skin samples

7/66 (10.6%)

1/57 (1.8%)

8/123 (6.5%)

No tumor
regression

Tumor
regression

All turtles

13/13 (100%)

22/26 (84.6%)

35/39 (89.7%)

All tumors (2016-2018)

Average viral
load for
positives (range)

13.1
(5.83 - 22.57)

538.8
(31.2 - 1739)

3.83e5
(68.6 – 2.69e6)

Blood samples of every storage type and year range had very low positive rates for ChHV5,
with the highest rate being 5.4% from older lysis buffer samples (1995-1999) of turtles with FP.
For skin samples, there was a small sample size for older skin samples (1999), with none of the 33
samples testing positive. Recent skin samples (2016-2018) had the highest ChHV5 positive rate
of all non-tumor samples, with 15.6% of samples from FP turtles testing positive, along with
producing the only positive from a non-FP turtle. There were no clear statistically significant
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differences in ChHV5 infection prevalence among blood and skin sample groups, likely due to the
low number of positive samples in all groups (Figure 8). For all positive samples, tumors generally
had viral loads two to four orders of magnitude higher than non-tumor tissues (Figure 9). Skin
samples had much higher viral loads than blood samples, roughly 50 times higher on average.

Figure 8: Results of a logistic regression analysis assessing the probability of a sampling testing
positive for chelonid herpesvirus 5 (ChHV5) via qPCR based on sample groups of juvenile green
turtles with and without fibropapillomatosis (FP) captured from 1995 to 2018 in the Indian River
Lagoon, FL, USA. Sample groups were based on sample type (blood and skin), sample
storage/location (frozen or lysis buffer for blood, shoulder or rear flipper for skin), timeframe of
sample collection, and whether or not the individual had external FP tumors. Filled in circles
represent groups with FP and open circles represent groups without FP. Lines with arrows
indicate 95% confidence intervals. Circles at probability zero with no confidence intervals
indicate groups with no positive samples, and were not included in the logistic regression
analysis. There were no statistically significant differences between sample groups included in
the logistic regression, likely due to the low numbers of positive samples in all groups.
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Figure 9: Boxplot of chelonid herpesvirus 5 (ChHV5) viral loads (number of gene copies) for
blood, skin, and tumor samples that tested positive for ChHV5 via qPCR. Samples were
collected from juvenile green turtles captured from 1995 to 2018 in the Indian River Lagoon, FL,
USA. The y-axis is in log-scale. Tumor samples generally had viral loads several orders of
magnitude higher than blood and skin samples. Skin samples typically had higher viral loads
than blood samples.

Extraction concentrations varied greatly within sample groups, with many samples below
10 ng/μL gDNA, and many well over 100 ng/μL gDNA (Figure 10). Most groups had relatively
sufficient DNA concentrations on average for qPCR (>30 ng/μL on average), with the exception
of recent blood lysis buffer samples and older skin samples both having low concentrations that
may have limited insight from qPCR for these groups. Positive skin and blood samples had DNA
concentrations ranging from 5.17 to 83.96 ng/μL, though all but one sample had concentrations
greater than 26 ng/μL. There were not enough positive samples overall to statistically assess the
effect of DNA concentration on the probability of a sample testing positive for ChHV5.
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Figure 10: Boxplot of DNA concentrations (ng/μL) by sample group for juvenile green turtle
blood and skin DNA extractions used in qPCR tests of chelonid herpesvirus 5 (ChHV5). Green
turtles were captured between 1995 and 2018 in the Indian River Lagoon, FL, USA. Sample
groups were based on sample type (blood and skin), sample storage/location (frozen or lysis
buffer for blood, shoulder or rear flipper for skin), and timeframe of sample collection. The yaxis is in log-scale.

From the 2016-2018 dataset, 39 individuals with FP had blood, skin, and tumor samples
that were each tested for ChHV5. Of the 39, two blood samples (5.1%), six skin samples (15.4%),
and 35 tumor samples (89.7%) tested positive (Table 5). Both turtles with positive blood samples
also had positive skin and tumor samples. Five of the six positive skin samples also had positive
tumor samples, but one positive skin sample came from a turtle with a negative tumor sample. All
four negative tumor samples came from turtles with signs of regressing FP (smoothing tumors).
However, it is unknown whether the specific samples tested were taken from a ‘regressing’
(smooth) tumor or an ‘active/proliferating’ (cauliflower-like) tumor, as turtles could have both
types of tumors at the same time. Additionally, 22 of the 39 turtles showed signs of regressing FP,
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with 18 of those having tumor samples test positive. From the logistic regression analysis, tumor
samples were more likely to test positive for ChHV5 than both blood and skin samples (Figure
11A). There were no clear statistical differences in ChHV5 prevalence between blood and skin
samples, again likely due to the low number of positives for blood and skin samples. For positive
samples, tumors had the highest viral loads, followed by skin and then blood (Figure 11B).

Table 5: Summary of chelonid herpesvirus 5 (ChHV5) qPCR test results for blood, skin, and
tumor samples collected from 39 juvenile green turtles with fibropapillomatosis (FP) captured
from 2016 to 2018 in the Indian River Lagoon, FL, USA. Each turtle had one sample of each
sample type (blood, skin, and tumor) tested for ChHV5 via qPCR. Viral load is shown in log
genome equivalents.

Sample
type

ChHV5
prevalence –
No tumor
regression

ChHV5
prevalence –
Tumor
regression

ChHV5
prevalence All turtles

Blood

1/13 (7.7%)

1/26 (3.8%)

2/39 (5.1%)

Skin

2/13 (15.4%)

4/26 (15.4%)

6/39 (15.4%)

Tumor

13/13 (100%)

22/26 (84.6%)

35/39 (89.7%)

Average viral
load for
positives
(range)
13.1
(9.9 – 16.4)
690.9
(32.5 - 1739)
3.83e5
(68.6 – 2.69e6)
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Figure 11: Results of chelonid herpesvirus 5 (ChHV5) qPCR testing of blood, skin, and tumor
samples collected from 39 juvenile green turtles captured from 2016 to 2018 in the Indian River
Lagoon, FL, USA. Each turtle had one sample of each sample type (blood, skin, and tumor)
tested for ChHV5 via qPCR. A) Results of logistic regression analysis assessing the probability
of a sampling testing positive for ChHV5 based on sample type. Tumors were more likely to test
positive than both blood and skin samples. There were no statistical differences between blood
and skin samples, likely due to the low number of positives for both sample types. B) Results of
bootstrapped means and 95% confidence intervals for ChHV5 viral loads (in log genome
equivalents) of positive samples for each sample type. There were only two blood samples that
tested positive, which were not enough data points to bootstrap confidence intervals. The point
for blood represents the mean of the two positive samples. Tumor samples had much higher viral
loads on average than skin samples, and skin samples had higher viral loads than blood samples.
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Discussion
We found very low prevalence of ChHV5 infections in blood (1.4% positive) and skin
(6.5% positive) samples, and high prevalence in tumor samples (89.7% positive). Blood and skin
qPCR provided little insight into broader ChHV5 infection dynamics. For turtles without FP, no
blood samples and only one skin sample tested positive for ChHV5, suggesting limited use for
qPCR testing of these sample types to characterize ChHV5 infections in non-FP turtles. Blood
samples were particularly unreliable for detecting ChHV5, as there were few positive samples and
all positives had viral loads below the reported limit of detection for this qPCR technique (50 gene
copies; Page-Karjian et al. 2015). Skin samples did show some evidence of consistency for
detecting ChHV5 infections, with all positives having viral loads well above the limit of detection.
This suggests localized infections in skin tissue can be consistently detected, but it is likely limited
in applicability as most positives (7 of 8, 87.5%) were from FP turtles. Positive skin samples may
represent tissue that could soon develop into tumors, as some skin samples had higher viral loads
than some tumor samples. It may be possible to detect ChHV5 infection in pre-FP turtles by taking
many skin samples from a single turtle, thereby increasing the chances of sampling a spot that will
develop into a tumor. However, this approach may be impractical due to the high number of
samples per individual that would likely be required to obtain meaningful results on ChHV5
dynamics.
Tumor tissues consistently tested positive for ChHV5 (35 of 39, 89.7%) with high viral
loads, consistent with previous analyses (Quackenbush et al. 2001, Rodenbusch et al. 2014, PageKarjian et al. 2015, Alfaro-Núñez et al. 2016, Monteiro et al. 2021). This provides further evidence
that ChHV5 plays a role in FP development. The four FP-positive turtles with negative qPCR
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results all had smooth tumors present, which is a sign of tumor regression. For example, recapture
data show tumors that decrease in size across captures are smooth at the second capture (Hirama
& Ehrhart 2007, Machado Guimaraes et al. 2013), and molecular analyses show that smooth
tumors have lower viral loads than papillary tumors (Rodenbusch et al. 2014). It is possible
regressing tumors contain very low levels of ChHV5 or no ChHV5, and that could explain the four
negative tumor samples from our dataset. However, it was not noted whether a sample was taken
from an apparently regressing tumor or an active tumor. Twenty-two of 35 positive tumors were
also from turtles with signs of tumor regression. Future research could compare ChHV5 prevalence
and viral loads in proliferating and regressing tumor samples, both within and among individual
turtles.
Our study analyzed a large number of older samples (448 samples were more than five
years old, ranging from 1995-2013). The oldest ChHV5 positive samples were four blood samples
collected in 1998 that were over 20 years old at the time of DNA extraction. However, overall the
older samples had just a 1.1% positive rate for ChHV5, compared to 5.3% for more recent samples
(2016-2018). This brings into question the viability of our older samples for ChHV5 testing. Lower
ChHV5 prevalence in older samples could be the result of several confounding factors (sample
age, storage type, who processed the samples). Additionally, most older samples were blood
(which had lower overall ChHV5 positive rates compared to skin), and even the skin samples
available were poor quality with low DNA concentrations. Older blood and skin samples are
probably fine for their original intended uses (turtle genetic studies) because there will still be
viable turtle DNA in the samples. But when there is already very little quantity of ChHV5 DNA
available in a latent infection of non-tumor tissue, older and poorly stored samples that have some
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DNA breakdown likely greatly diminish detection of ChHV5 via qPCR. The uncertainty of DNA
quality for older samples makes it difficult to determine whether degraded/inhibited samples led
to false negatives or if there were simply very few actual positives, a common issue in assessing
pathogen presence in older samples (Harkins et al. 2014, Muletz et al. 2014, Stone & Ozga 2019).
When considering only the recent samples (2016-2018), blood and skin ChHV5 positive
rates were still low at 2.0% and 8.9%, respectively. These low rates of positives were similar to
some studies (Lawrance et al. 2018: 6% in blood and 3% in skin; James et al. 2021: 0% in both
blood and skin; Perrault et al. 2021: 3% in blood), but other studies had much higher rates of
positives for both blood and skin, especially for turtles without FP (Quackenbush et al. 2001:
34.6% in skin and 21.4% in skin of no-FP turtles; Page-Karjian et al. 2015: 42.5% in skin and
22.2% in skin of no-FP turtles, 32.3% in blood and 25.8% in blood of no-FP turtles; Monteiro et
al. 2021: 28% in blood and 20.8% in blood of no-FP turtles). It is unclear why such great
differences exist in positive rates of blood and skin samples between studies. This study, Lawrance
et al. (2018) and Perrault et al. (2021) all had low positive rates despite testing turtles from high
FP prevalence aggregations in Florida. Thus, regional differences in infection dynamics may
contribute to differences in positive rates between studies. Still, the inconsistency of qPCR results
between studies causes concern for the applicability of qPCR in assessing ChHV5 infection
dynamics, especially for comparisons among studies. Therefore, our results (and others) should be
considered with caution until causes of differences are further clarified.
Considering that most green turtles in the IRL likely have or have had FP (Kelley et al. in
press), and assuming ChHV5 is the pathogen of FP, qPCR testing of blood and skin samples was
ineffective for identifying ChHV5 infection if the infection status of the animal itself (not just the
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sample) is the desired result. This was particularly true for turtles without FP, which are the main
subject of interest when it comes to ChHV5 infection dynamics because we already know turtles
with FP are infected with ChHV5. Skin is probably better at detecting non-tumor infections than
blood, but still was not reliable for latent infections in non-FP turtles. Therefore, we do not
recommend using qPCR of either skin or blood samples to assess ChHV5 prevalence in a turtle
aggregation or other grouping of turtles.
While we show here that qPCR of blood and skin samples provided limited information on
the ChHV5 infection status of an individual, there may be other non-tumor tissues that could
provide better representation of infection status. In particular, qPCR of kidney and urine samples
may be of interest. Kidneys could become infected by filtering ChHV5 particles from ingested
virus in the water column (Farrell et al. 2021). Though there is very little information available on
qPCR of kidney samples, one study had 4 of 5 samples with FP and 1 of 5 without FP test positive
for ChHV5 (Page-Karjian et al. 2017). While testing kidney samples is highly invasive and not
feasible for live animals, urine samples may contain some ChHV5 particles shed from the kidneys.
The combined results of two studies that tested urine samples for ChHV5 had positives in 9 of 13
turtles with a history of FP and 1 of 9 without FP (Page-Karjian et al. 2015, Page-Karjian et al.
2017). Additionally, if ChHV5 ingestion and infection of kidneys is a mode of initial ChHV5
infection, urine samples may be a way to detect infection before disease progression. Future work
could investigate using qPCR of urine samples to detect pre-FP ChHV5 infections.
An alternative testing technique available for detecting ChHV5 infections is an enzymelinked immunosorbent assay (ELISA) that detects antibodies for ChHV5 (Herbst et al. 2008).
Testing for ChHV5 via ELISA is shown to be more sensitive than qPCR in several studies (Page42

Karjian et al. 2020, James et al. 2021, Perrault et al. 2021), though ELISA tests sometimes do not
detect infections that qPCR tests detect (Page-Karjian et al. 2020). Because ELISA tests for
ChHV5 antibodies, it is not suited for detecting early infections before the turtle has had enough
time to mount an acquired immune response. However, ELISA testing could be useful for
assessing exposure to ChHV5, particularly for FP recovered individuals. ELISA and qPCR could
also be used together to better characterize ChHV5 prevalence in a group of turtles.
Overall, directly assessing ChHV5 infection status is difficult for turtles without visible
signs of FP. Testing skin and blood samples, the most commonly collected samples for sea turtle
disease studies, via qPCR does not appear to be a viable option for characterizing ChHV5 infection
dynamics, likely due to the low probability of ChHV5 being present in a blood or skin sample
when a turtle has a latent infection. Other sample types and methods may improve ChHV5
detection, but the cryptic nature of latent herpesvirus infections will likely make it difficult to fully
understand the infection dynamics of ChHV5. Going forward, investigations of the role of ChHV5
in FP development could look at other aspects of ChHV5 virology besides incidence and
prevalence, and assess how those coincide with environmental and immune factors to establish
symptomatic FP.

43

REFERENCES
Aguirre A.A. 1991. Green turtle fibropapilloma: an epidemiologic perspective. In: Balazs GH,
Pooley SG (eds.) Research plan for marine turtle fibropapilloma. U.S. Department of
Commerce, National Oceanographic and Atmospheric Administration, National Marine
Fisheries Service. NOAA-TM-NMFSSWFSC-156, pp. 107-113.
Aguirre A.A., P.L. Lutz. 2004. Marine turtles as sentinels of ecosystem health: Is
fibropapillomatosis an indicator? EcoHealth 1:275-283.
Alfaro-Núñez A., A. Miki Bojesen, M.F. Bertelsen, N. Wales, G.H. Balazs, M.T.P. Gilbert. 2016.
Further evidence of Chelonid herpesvirus 5 (ChHV5) latency: high levels of ChHV5 DNA
detected in clinically healthy marine turtles. PeerJ 4:e2274.
Bagley D.A. 2003. Characterizing juvenile green turtles, (Chelonia mydas), from three east central
Florida developmental habitats. MS dissertation, University of Central Florida, Orlando,
FL.
Balazs G.H. 1999. Factors to consider in the tagging of sea turtles. Pages 101-109 in K. L. Eckert,
K. A. Bjorndal, F. A. Abreu-Grobois, and M. Donnelly, editors. Research and management
techniques for the conservation of sea turtles. IUCN/SSC Marine Turtle Specialist Group
Publication No. 4.
Bolten A.B. 1999. Techniques for Measuring Sea Turtles. Pages 110-114 in Eckert KL, K. A.
Bjorndal KA, Abreu-Grobois A, and Donnelly M, editors. Research and management
techniques for the conservation of sea turtles. IUCN/SSC Marine Turtle Specialist Group
Publication No. 4.

44

Bolten, A.B. 2003. Variation in sea turtle life history patterns: neritic vs. oceanic developmental
stages. Pages 243–257 in P. L. Lutz, J. A. Musick, and J. Wyneken, editors. The biology
of sea turtles, volume II. CRC Press, Boca Raton, Florida, USA.
Borrowman K.M. 2008. Prevalence and severity of fibropapillomatosis in juvenile green turtles
(Chelonia mydas) in three habitats on Florida’s east coast. MS dissertation, University of
Central Florida, Orlando, FL.
Brooks D., P. Ginn, T. Miller, L. Bramson, E. Jacobson. 1994. Ocular Fibropapillomas of Green
Turtles (Chelonia mydas). Veterinary Pathology 31:335-339.
Chabot R.M., R.C. Welsh, C.R. Mott, J.R. Guertin, B.M. Shamblin, B.E. Witherington 2021. A
sea turtle population assessment for Florida’s Big Bend, Northeastern Gulf of Mexico. Gulf
and Caribbean Research 32:19-33.
Chaloupka M., G. Balazs, T. Work. 2009. Rise and Fall over 26 Years of a Marine Epizootic
Hawaiian Green Sea Turtles. Journal of Wildlife Diseases 45(4):1138-1142.
Chaloupka M., T. Work, G. Balazs, S. Murakawa, R. Morris 2008. Cause-specific temporal and
spatial trends in green sea turtle strandings in the Hawaiian Archipelago (1982–2003).
Marine Biology 154:887-898.
Colman L.P., A.R.C. Patrício, A. McGowan, A.J.B. Santos, M.Â. Marcovaldi, C. Bellini, B.J.
Godley. 2015. Long-term growth and survival dynamics of green turtles (Chelonia mydas)
at an isolated tropical archipelago in Brazil. Marine Biology 162(1):111–122.
Daszak P., A.A. Cunningham, A.D. Hyatt. 2000. Emerging infectious diseases of wildlife – threats
to biodiversity and human health. Science 287:443-449.

45

Daszak P., A.A. Cunningham, A.D. Hyatt. 2001. Anthropogenic environmental change and the
emergence of infectious diseases in wildlife. Acta Tropica 78:103-116.
Direnzo G.V., E.H. Campbell Grant. 2019. Overview of emerging amphibian pathogens and
modeling advances for conservation-related decisions. Biological Conservation 236:474483.
dos Santos R.G., A.S. Martins, E. Torezani, C. Baptistotte, J.D. Farias, P.A. Horta, T.M. Work,
G.H. Balazs. 2010. Relationship between fibropapillomatosis and environmental quality: a
case study with Chelonia mydas off Brazil. Diseases of Aquatic Organisms 89:87-95.
Edmunds D.R., M.J. Kauffman, B.A. Schumaker, F.G. Lindzey, W.E. Cook, T.J. Kreeger, R.G.
Grogan, T.E. Cornish. 2016. Chronic wasting disease drives population decline of whitetailed deer. PLoS ONE 11(8):e0161127.
Ehrhart L.M. 1991. Fibropapillomas in green turtles of the Indian River Lagoon, Florida:
distribution over time and area. In: Balazs GH, Pooley SG (eds) Research plan for marine
turtle fibropapilloma. NOAA Tech. Memo. NOAA-TM-NMFS-SWFSC-156. US
Department of Commerce, La Jolla, CA, p 59–61.
Ehrhart L.M., W.E. Redfoot, D.A. Bagley. 2007. Marine turtles of the central region of the Indian
River Lagoon system, Florida. Florida Scientist 70:415–434.
Ene A., M. Su, S. Lemaire, C. Rose, S. Schaff, R. Moretti, J. Lenz, L.H. Herbst. 2005. Distribution
of chelonid fibropapillomatosis-associated herpesvirus variants in Florida: molecular
genetic evidence for infection of turtles following recruitment to neritic developmental
habitats. Journal of Wildlife Diseases 41:489–497.

46

Farrell J.A., K. Yetsko, L. Whitmore, J. Whilde, C.B. Eastman, D.R. Ramia, R. Thomas, P, Linser,
S. Creer, B. Burkhalter, C. Schnitzler, D.J. Duffy. 2021. Environmental DNA monitoring
of oncogenic viral shedding and genomic profiling of sea turtle fibropapillomatosis reveals
unusual viral dynamics. Communications Biology 4:565.
Flint M., J.C. Patterson-Kane, C.J. Limpus, P.C. Mills. 2010. Health surveillance of stranded green
turtles in southern Queensland, Australia (2006--2009): An epidemiological analysis of
causes of disease and mortality. EcoHealth 7:135.
Foley A.M., B.A. Schroeder, A.E. Redlow, K.J. Fick-Child, W.G. Teas. 2005. Fibropapillomatosis
in stranded green turtles (Chelonia mydas) from the eastern United States (1980-98): trends
and associations with environmental factors. Journal of Wildlife Diseases 41:29–41.
Formia A., S. Deem, A. Billes, S. Ngouesssono, R. Parnell, T. Collins, G.P. Soundguet, A. Gibudi,
A. Villarubia, G.H. Balazs, T.R. Spraker. 2007. Fibropapillomatosis confirmed in Chelonia
mydas in the Gulf of Guinea, West Africa. Marine Turtle Newsletter 116:20-22.
Garner T.W.J., M.W. Perkins, P. Govindarajulu, D. Seglie, S. Walker, A.A. Cunningham, M.C.
Fisher. 2005. The emerging amphibian pathogen Batrachochytrium dendrobatidis globally
infects introduced populations of the North American bullfrog, Rana catesbeiana. Biology
Letters 2(3):455-459.
Gorham J.C., M.J. Bresette, J.R. Guertin, B.M. Shamblin, C.J. Nairn. 2016. Green turtles
(Chelonia mydas) in an urban estuary system: Lake Worth Lagoon, Florida. Florida
Scientist 79(1):14-27.

47

Hancock J.M., S. Vieira, V. Jimenez, J.C. Rio, R. Rebelo. 2018. Stable isotopes reveal dietary
differences and site fidelity in juvenile green turtles foraging around Sao Tome Island,
West Central Africa. Marine Ecology Progress Series 600:165-177.
Hargrove S.A., T.M. Work, S. Brunson, A.M. Foley, G.H. Balazs. 2016. Proceedings of the 2015
international summit on fibropapillomatosis: global status, trends, and population impacts.
U.S. Dep. Commer., NOAA Tech. Memo., NOAA-TM-NMFS-PIFSC54, 87p.
Hardman K., A. Dastjerdi, R. Gurrala, A. Routh, M. Banks, F. Steinbach, T. Bouts. 2011.
Detection of elephant endotheliotropic herpesvirus type 1 in asymptomatic elephants using
TaqMan real-time PCR. Veterinary Record 170(8):205.
Harkins K.M., J.E. Buikstra, T. Campbell, K.I. Bos, E.D. Johnson, J. Krause, A.C. Stone. 2014.
Screening ancient tuberculosis with qPCR: challenges and opportunities. Philosophical
Transactions B 370:20130622.
Herbst L.H. 1994. Fibropapillomatosis of marine turtles. Annu Rev Fish Dis 4:389–425.
Herbst L.H., E.R. Jacobson, R. Moretti, T. Brown, J.P. Sundberg, P.A. Klein. 1995. Experimental
transmission of green turtle fibropapillomatosis using cell-free tumor extracts. Diseases of
Aquatic Organisms 22:1–12.
Herbst L.H., S. Lemaire, A.R. Ene, D.J. Heslin, L.M. Ehrhart, D.A. Bagley, P.A. Klein, J. Lenz.
2008. Use of baculovirus-expressed glycoprotein H in an enzyme-linked immunosorbent
assay developed to assess exposure to Chelonid Fibropapillomatosis-Associated
Herpesvirus and its relationship to the prevalence of fibropapillomatosis in sea turtles.
Clinical and Vaccine Immunology 15(5):843-851.

48

Hidalgo-Vila J., A. Martinez-Silvestre, N. Perez-Santigosa, L. Leon-Vizcaino, C. Diaz-Paniagua.
2020. High prevalence of diseases in two invasive populations of red-eared sliders
(Trachemys scripta elegans) in southwestern Spain. Amphibia-reptilia 41(4):509-518.
Hirama S., L.M. Ehrhart. 2007. Description, prevalence and severity of green turtle
fibropapillomatosis in three developmental habitats on the east coast of Florida. Florida
Scientist 70:435–448.
Hoyt J.R., A.M. Kilpatrick, K.E. Langwig. 2021. Ecology and impacts of white-nose syndrome on
bats. Nature Reviews Microbiology 19:196-210.
Jacobson E.R., M.B. Brown, L.D. Wendland, D.R. Brown, P.A. Klein, M.M. Christopher, K.H.
Berry. 2014. Mycoplasmosis and upper respiratory tract disease of tortoises: A review and
update. The Veterinary Journal 201(3):257-264.
James A., A. Page-Karjian, K.E. Charles, J. Edwards, C.R. Gregory, S. Cheetham, B.P. Buter, D.P.
Marancik. 2021. Chelonid Alphaherpesvirus 5 prevalence and first confirmed case of sea
turtle fibropapillomatosis in Grenada, West Indies. Animals 11:1490.
Jones K., E. Ariel, G. Burgess, M. Read. 2016. A review of fibropapillomatosis in green turtles
(Chelonia mydas). The Veterinary Journal 212:48–57.
Jones, T. T., and J. A. Seminoff 2013. Feeding biology: advances from field-based observations,
physiological studies, and molecular techniques. Pages 211–248 in J. Wyneken, K. J.
Lohmann, and J. A. Musick, editors. The biology of sea turtles. Volume III. CRC Press,
Boca Raton, Florida, USA.
Kelley J.R., K.L. Kelley, A.E. Savage, K.L. Mansfield. In press. Novel disease state model finds
most juvenile green turtles develop and recover from fibropapillomatosis. Ecosphere.
49

Kilpatrick C.W. 2001. Noncryogenic preservation of mammalian tissue for DNA extraction: An
assessment of storage methods. Biochemical Genetics 40(1/2):53-62.
King C.E., R. Debruyne, M. Kuch, C. Schwarz, H.N. Poinar. 2009. A quantitative approach to
detect and overcome PCR inhibition in ancient DNA extracts. BioTechniques 47:941-949.
Lawrance M.F., K.L. Mansfield, E. Sutton, A.E. Savage. 2018. Molecular evolution of
fibropapilloma-associated herpesviruses infecting juvenile green and loggerhead sea
turtles. Virology 521:190–197.
Long C.A., R.M. Chabot, M.N. El-Khazen, J.R. Kelley, C. Mollet-Saint Benoit, K.L. Mansfield.
2021. Incongruent long-term trends of a marine consumer and primary producers in a
habitat affected by nutrient pollution. Ecosphere 12(6):e03553.
Lucké B. 1938. Studies on tumors in cold-blooded vertebrates. Annu Rep Tortugas Lab Carnegie
Inst:92–94.
Lunn D.J., A. Thomas, N. Best, D. Spiegelhalter. 2000. WinBUGS — a Bayesian modelling
framework: concepts, structure, and extensibility. Statistics and Computing 10:325–337.
Lutz P.L., J.A. Musick, J. Wyneken. 1997. The biology of sea turtles. CRC Press.
Machado Guimarães S., H. Mas Gitirana, A. Vidal Wanderley, C. Monteiro-Neto, G. Lobo-Hajdu.
2013. Evidence of regression of fibropapillomas in juvenile green turtles Chelonia mydas
caught in Niterói, southeast Brazil. Diseases of Aquatic Organisms 102:243-247.
Mansfield K., J. Kelley, A. Savage, K. Kelley. 2021. Novel disease state model finds most juvenile
green turtles develop and recover from fibropapillomatosis, Dryad, Dataset,
https://doi.org/10.5061/dryad.ttdz08kzn

50

Mansfield K.L., J. Wyneken, J. Luo. 2021. First Atlantic satellite tracks of ‘lost years’ green
turtles support the importance of the Sargasso Sea as a sea turtle nursery. Proceedings of
the Royal Society B 288:20210057.
Martin K., A.E. Savage, K.L. Mansfield. (in review) Functional immune gene variation in sea
turtles predicts fibropapillomatosis tumor development and regression.
Maunder M.N., A.E. Punt. 2013. A review of integrated analysis in fisheries stock assessment.
Fisheries Research 142:61-74.
Mendonça M.T. 1983. Movements and feeding ecology of immature green turtles (Chelonia
mydas) in a Florida lagoon. Copeia 1983:1013–1023.
Monteiro J., M. Duarte, K. Amadou, C. Barbosa, N. El Bar, F.M. Madeira, A. Regalla, A. Duarte,
L. Tavares, A.R. Patrıcio. 2021. Fibropapillomatosis and the Chelonid Alphaherpesvirus 5
in Green Turtles from West Africa. EcoHealth 18:229-240.
Muletz C., N.M. Caruso, R.C. Fleischer, R.W. McDiarmid, K.R. Lips. 2014. Unexpected Rarity
of the Pathogen Batrachochytrium dendrobatidis in Appalachian Plethodon Salamanders:
1957–2011. PLOS ONE 9(8):e103728.
Page-Karjian A., N.L. Gottdenker, J. Whitfield, L. Herbst, T.M. Norton, B. Ritchie. 2017. Potential
noncutaneous sites of Chelonid Herpesvirus 5 persistence and shedding in green sea turtles
Chelonia mydas. Journal of Aquatic Animal Health 29:136-142.
Page-Karjian A., M.E. Serrano, J. Cartzendafner, A. Morgan, B.W. Ritchie, C.R. Gregory, J.B.
McNeill, J.R. Perrault, E.F. Christiansen, C.A. Harms. 2020. Molecular assessment of
Chelonid Alphaherpesvirus 5 infection in tumor-free green (Chelonia mydas) and

51

loggerhead (Caretta caretta) sea turtles in North Carolina, USA, 2015–2019. Animals
10:1964.
Page-Karjian A., T.M. Norton, B. Ritchie, C. Brown, C. Mancia, M. Jackwood, N.L. Gottdenker.
2015. Quantifying chelonid herpesvirus 5 in symptomatic and asymptomatic rehabilitating
green sea turtles. Endangered Species Research 28:135–146.
Patrício A.R., C.E. Diez, R.P. van Dam, B.J. Godley. 2016. Novel insights into the dynamics of
green turtle fibropapillomatosis. Marine Ecology Progress Series 547:247-255.
Patrício A.R., X. Vélez-Zuazo, C. Diez. 2011. Survival probability of immature green turtles in
two foraging grounds at Culebra, Puerto Rico. Marine Ecology Progress Series 440:217–
227.
Permenter J., A. Ishwar, A. Rounsavall, M. Smith, J. Faske, C.J. Sailey, M.P. Alfaro. 2015.
Quantitative analysis of genomic DNA degradation in whole blood under various storage
conditions for molecular diagnostic testing. Molecular and Cellular Probes 29:449-453.
Perrault J.R., M. Levin, C.R. Mott, C.M. Bovery, M.J. Bresette, R.M. Chabot, C.R. Gregory, J.R.
Guertin, S.E. Hirsch, B.W. Ritchie, S.T. Weege, R.C. Welsh, B.E. Witherington, A. PageKarjian. 2021. Insights on immune function in free-ranging green sea turtles (Chelonia
mydas) with and without fibropapillomatosis. Animals 11:861.
Peterson J.D., M.B. Wood, W.A. Hopkins, J.M. Unrine, M.T. Mendonca. 2007. Prevalence of
Batrachochytrium dendrobatidis in American bullfrog and southern leopard frog larvae
from wetlands on the Savannah River Site, South Carolina. Journal of Wildlife Diseases
43(3):450-460.

52

Pilcher N. 2010. Population structure and growth of immature green turtles at Mantanani, Sabah,
Malaysia. Journal of Herpetology 44(1):168–171.
Prober C. 2005. Sixth Disease and the Ubiquity of Human Herpesviruses. The New England
Journal of Medicine 352(8):753-755.
Quackenbush S.L., T.M. Work, G.H. Balazs, R.N. Casey, J. Rovnak, A. Chaves, L. DuToit, J.D.
Baines, C.R. Parrish, P.R. Bowser, J.W. Casey. 1998. Three closely related herpesviruses
are associated with fibropapillomatosis in marine turtles. Virology 246:392–399.
Quackenbush S.L., R.N. Casey, R.J. Murcek, T.A. Paul, T.M. Work, C.J. Limpus, A. Chaves, L.
duToit, J.V. Perez, A.A. Aguirre, T.R. Spraker, J.A. Horrocks, L.A. Vermeer, G.H. Balazs,
J.W. Casey. 2001. Quantitative Analysis of Herpesvirus Sequences from Normal Tissue
and Fibropapillomas of Marine Turtles with Real-Time PCR. Virology 287(1):105-111.
R Core Team. 2021. R: A language and environment for statistical computing. R Foundation for
Statistical Computing, Vienna, Austria. URL https://www.R-project.org/.
Redfoot W.E., L.M. Ehrhart. 2008. Determining home ranges and the use of habitat by juvenile
green turtles in the central region of the Indian River Lagoon system, Florida. Final Report
submitted for US Fish and Wildlife Service Agreement No. 401815G053.
Rittenburg L.T., J.R. Kelley, K.L. Mansfield, A.E. Savage. 2021. Marine leech parasitism of sea
turtles varies across host species, seasons, and the tumor disease fibropapillomatosis.
Diseases of Aquatic Organisms 143:1-12.
Rodenbusch C.R., C. Baptistotte, M.R. Werneck, T.T. Pires, M.T.D. Melo, M.W. de Ataíde,
K.D.H.L. dos Reis, P. Testa, M.M. Alieve, C.W. Canal. 2014. Fibropapillomatosis in green

53

turtles Chelonia mydas in Brazil: characteristics of tumors and virus. Diseases of Aquatic
Organisms 111:207-217.
Roizman, B. 1982. The Family Herpesviridae: General Description, Taxonomy, and
Classification. Plenum Press, New York.
Sawicka-Durkalec A., O. Kursa, L. Bednarz, G. Tomczyk. 2021. Occurrence of Mycoplasma spp.
in wild birds: phylogenetic analysis and potential factors affecting distribution. Scientific
Reports 11:17065.
Schloegel L.M., C.M. Ferreira, T.Y. James, M. Hipolito, J.E. Longcore, A.D. Hyatt, M. Yabsley,
A.M.C.R.P.F Martins, R. Mazzoni, A.J. Davies, P. Daszak. 2009. The North American
bullfrog as a reservoir for the spread of Batrachochytrium dendrobatidis in Brazil. Animal
Conservation 13(1):53-61.
Seminoff, J.A., C.D. Allen, G.H. Balazs, P.H. Dutton, T. Eguchi, H.L. Haas, S.A. Hargrove, M.P.
Jensen, D.L. Klemm, A.M. Lauritsen, S.L. MacPherson, P. Opay, E.E. Possardt, S.L. Pultz,
E.E. Seney, K.S. Van Houtan, R.S. Waples. 2015. Status Review of the Green Turtle
(Chelonia mydas) Under the U.S. Endangered Species Act. NOAA Technical
Memorandum NOAANMFS-SWFSC:539-571.
Shimada T., S. Aoki, K. Kameda, J. Hazel, K. Reich, N. Kamezaki. 2014. Site fidelity, ontogenetic
shift and diet composition of green turtles Chelonia mydas in Japan inferred from stable
isotope analysis. Endangered Species Research 25(2):151-164.
Siegwalt F., S. Benhamou, M. Girondot, L. Jeantet, J. Martin, et al. 2020. High fidelity of sea
turtles to their foraging grounds revealed by satellite tracking and capture-mark-recapture:

54

New insights for the establishment of key marine conservation areas. Biological
Conservation 250:108742.
Skerratt L.F., L. Berger, R. Speare, S. Cashins, K.R. McDonald, A.D. Phillott, H.B. Hines, N.
Kenyon. 2007. Spread of chytridiomycosis has caused the rapid global decline and
extinction of frogs. EcoHealth 4:125-134.
Smith G.M., C.W. Coates. 1938. Fibro-epithelial growths of the skin in large marine turtles,
Chelonia mydas (Linnaeus). Zoologica 23:93–98.
Stone A.C., A.T. Ozga. 2019. Ancient DNA in the study of ancient disease. In: Ortner’s
Identification of Pathological Conditions in Human Skeletal Remains. Elsevier.
Sturtz S., U. Ligges, A. Gelman. 2005. R2WinBUGS: A Package for Running WinBUGS from R.
Journal of Statistical Software 12(3):1–16.
Tompkins D.M., S. Carver, M.E. Jones, M. Krkosek, L.F. Skerratt. 2015. Emerging infectious
diseases of wildlife: a critical perspective. Trends in Parasitology 31(4):149-159.
Van Houtan K.S., S.K. Hargrove, G.H. Balazs. 2010. Land Use, Macroalgae, and a TumorForming Disease in Marine Turtles. PLoS ONE 5(9):e12900.
Work T.M., G.H. Balazs, R.A. Rameyer, R.A. Morris. 2004. Retrospective pathology survey of
green turtles Chelonia mydas with fibropapillomatosis in the Hawaiian Islands, 1993-2003.
Diseases of Aquatic Organisms 62:163-176.
Work T.M., J. Dagenais, G.H. Balazs, N. Schettle, M. Ackermann. 2014. Dynamics of virus
shedding and in situ confirmation of chelonid herpesvirus 5 in Hawaiian green turtles with
fibropapillomatosis. Veterinary Pathology 52:1195–1201.

55

Zipkin E.F., S.P. Saunders. 2018. Synthesizing multiple data types for biological conservation
using integrated population models. Biological Conservation 217:240-250.

56

